Login to Your Account



Santarus Getting Rights to GI Drugs in Deal with Cosmo

By Catherine Hollingsworth


Tuesday, December 16, 2008
Seeking to grow its pipeline, San Diego-based Santarus agreed to collaborate with Italian specialty drug firm Cosmo Technologies Ltd. to develop and commercialize two compounds targeting the colon in a deal worth up to $87 million plus royalties. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription